http://jcps.bjmu.edu.cn
卡瑞利珠单抗, 一种人源化抗PD-1 IgG4亚型单克隆抗体在临床前研究中表现出优异的抗肿瘤活性以及良好的安全性
孙星, 杨昌永, 林侃, 周彩红, 廖成, 张利敏, 金薪盛, 毛浪勇, 应华, 陶维康, 张连山
Camrelizumab (SHR-1210), a humanized anti-PD-1 IgG4 mAb, exhibits superior anti-tumor activity and a favorable safety profile in preclinical studies
Xing Sun, Changyong Yang, Kan Lin, Caihong Zhou, Chen Liao, Limin Zhang, Xinsheng Jin, Langyong Mao, Hua Ying, Weikang Tao, Lianshan Zhang
中国药学(英文版) . 2021, (5): 393 -408 .  DOI: 10.5246/jcps.2021.05.031